ALNYLAM PHARMACEUTICALS INC

ALNYNASDAQ

🏆 #357 by market capEarnings Oct 29Biotech

$990.00▲ $68.21 (+6.89%)

Simulated price

1h—

24h▲ 6.9%

7d—

14d—

30d—

1y—

🏦Market Cap

$29.03B

Mid Cap

📈Revenue Growth (YoY)

+95.1%

High Growth

📊Gross Margin

79.7%

High

💵FCF Margin

16.5%

Healthy

⚖️P/S Ratio

6.1x

Fair

Otter Score

63

Fair

🔭

No analyst ratings for ALNY

We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.